Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1646249609;49610;49611 chr2:178613899;178613898;178613897chr2:179478626;179478625;179478624
N2AB1482144686;44687;44688 chr2:178613899;178613898;178613897chr2:179478626;179478625;179478624
N2A1389441905;41906;41907 chr2:178613899;178613898;178613897chr2:179478626;179478625;179478624
N2B739722414;22415;22416 chr2:178613899;178613898;178613897chr2:179478626;179478625;179478624
Novex-1752222789;22790;22791 chr2:178613899;178613898;178613897chr2:179478626;179478625;179478624
Novex-2758922990;22991;22992 chr2:178613899;178613898;178613897chr2:179478626;179478625;179478624
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATC
  • RefSeq wild type template codon: TAG
  • Domain: Fn3-7
  • Domain position: 13
  • Structural Position: 15
  • Q(SASA): 0.2754
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V None None 0.02 N 0.178 0.118 0.222439326576 gnomAD-4.0.0 1.59975E-06 None None None None N None 0 0 None 0 0 None 0 0 2.87181E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.7268 likely_pathogenic 0.6831 pathogenic -2.009 Highly Destabilizing 0.91 D 0.489 neutral None None None None N
I/C 0.8058 likely_pathogenic 0.7669 pathogenic -1.791 Destabilizing 0.999 D 0.569 neutral None None None None N
I/D 0.9621 likely_pathogenic 0.9568 pathogenic -1.848 Destabilizing 0.998 D 0.711 prob.delet. None None None None N
I/E 0.897 likely_pathogenic 0.882 pathogenic -1.789 Destabilizing 0.993 D 0.719 prob.delet. None None None None N
I/F 0.4461 ambiguous 0.3959 ambiguous -1.501 Destabilizing 0.991 D 0.519 neutral D 0.538977234 None None N
I/G 0.944 likely_pathogenic 0.9254 pathogenic -2.384 Highly Destabilizing 0.993 D 0.707 prob.neutral None None None None N
I/H 0.8866 likely_pathogenic 0.8487 pathogenic -1.663 Destabilizing 0.999 D 0.707 prob.neutral None None None None N
I/K 0.7617 likely_pathogenic 0.7104 pathogenic -1.387 Destabilizing 0.993 D 0.715 prob.delet. None None None None N
I/L 0.2653 likely_benign 0.2491 benign -1.011 Destabilizing 0.58 D 0.305 neutral N 0.480387084 None None N
I/M 0.2275 likely_benign 0.2031 benign -1.039 Destabilizing 0.991 D 0.519 neutral D 0.564050684 None None N
I/N 0.7503 likely_pathogenic 0.7154 pathogenic -1.378 Destabilizing 0.997 D 0.717 prob.delet. D 0.595272277 None None N
I/P 0.9364 likely_pathogenic 0.934 pathogenic -1.316 Destabilizing 0.998 D 0.721 prob.delet. None None None None N
I/Q 0.8274 likely_pathogenic 0.7819 pathogenic -1.527 Destabilizing 0.998 D 0.712 prob.delet. None None None None N
I/R 0.7193 likely_pathogenic 0.6651 pathogenic -0.891 Destabilizing 0.993 D 0.714 prob.delet. None None None None N
I/S 0.7313 likely_pathogenic 0.6897 pathogenic -2.071 Highly Destabilizing 0.991 D 0.604 neutral N 0.478272049 None None N
I/T 0.4741 ambiguous 0.4316 ambiguous -1.884 Destabilizing 0.939 D 0.512 neutral N 0.481654547 None None N
I/V 0.0811 likely_benign 0.0776 benign -1.316 Destabilizing 0.02 N 0.178 neutral N 0.428017559 None None N
I/W 0.9397 likely_pathogenic 0.9292 pathogenic -1.606 Destabilizing 0.999 D 0.701 prob.neutral None None None None N
I/Y 0.8259 likely_pathogenic 0.7819 pathogenic -1.341 Destabilizing 0.998 D 0.593 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.